Cargando…
Critical threshold levels of DNA methyltransferase 1 are required to maintain DNA methylation across the genome in human cancer cells
Reversing DNA methylation abnormalities and associated gene silencing, through inhibiting DNA methyltransferases (DNMTs) is an important potential cancer therapy paradigm. Maximizing this potential requires defining precisely how these enzymes maintain genome-wide, cancer-specific DNA methylation. T...
Autores principales: | Cai, Yi, Tsai, Hsing-Chen, Yen, Ray-Whay Chiu, Zhang, Yang W., Kong, Xiangqian, Wang, Wei, Xia, Limin, Baylin, Stephen B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378172/ https://www.ncbi.nlm.nih.gov/pubmed/28232479 http://dx.doi.org/10.1101/gr.208108.116 |
Ejemplares similares
-
DNA methyltransferases are complementary in maintaining DNA methylation in embryonic stem cells
por: Liu, Yuhan, et al.
Publicado: (2022) -
DNA methylation and DNA methyltransferases
por: Edwards, John R., et al.
Publicado: (2017) -
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
por: Li, Huili, et al.
Publicado: (2014) -
Diversity of Fungal DNA Methyltransferases and Their Association With DNA Methylation Patterns
por: Nai, Yu-Shin, et al.
Publicado: (2021) -
Mediating and maintaining methylation while minimizing mutation: Recent advances on mammalian DNA methyltransferases
por: Cheng, Xiaodong, et al.
Publicado: (2022)